SRI International said Monday it was awarded an $8.3 million contract to develop broad-spectrum antibiotics from the Defense Threat Reduction Agency, an agency within the United States Department of Defense.
SRI International said Monday it was awarded an $8.3 million contract to develop broad-spectrum antibiotics from the Defense Threat Reduction Agency, an agency within the United States Department of Defense.